Year in Review
Fostering connections and unveiling new horizons
In 2025, our coalition projects broadened across multiple regions, and we proudly expanded our support to include haemoglobinopathies as well as haemophilia.
Forging our future from our legacy
In 2024, the diversity of our programmes was showcased with 2 new countries joining our portfolio, whilst others marked more than ten years of NNHF partnership.
Stronger network, greater impact
Explore our 2023 impact report to see how our partners are reducing distance to care, increasing diagnosis, improving health outcomes, and driving systemic change.
Half‑Year Programme Reports
Half-Year Programme Report July-December 2025
The Half-Year Programme Report highlights the significant programme updates from partners around the world made between July and December 2025.
Half-Year Programme Report January-June 2025
The Half-Year Programme Report highlights the significant programme updates from partners around the world made between January and June 2025.
Half-Year Programme Report July-December 2024
The Half-Year Programme Report highlights the significant programme updates from partners around the world made between July and December 2024.
NNHF Brochure
NNHF Brochure
Since 2005, together with our partners, we at the Novo Nordisk Haemophilia & Haemoglobinopathies Foundation (NNHF) have been striving to improve access to care for people living with these disorders.
Impacting care episodes
Kenya’s journey to build the future of haemophilia care (EP1)
In this podcast dr Kibet Shukuku talks about the steps to build up care in Kenya, the challenges and the achievements.
Building a multidisciplinary haemophilia care centre from scratch (EP2)
In this episode you will hear about dr Laura Villarreal’s vision of a multidisciplinary care team and how she was able to build it.
How a team from Transylvania impacted haemophilia care across Romania (EP3)
Find out how dr Ciprian Tomuleasa and his team in the city of Cluj Napoca improved the care and treatment delivery for people with hemophilia.
